CVS Pulling Popular Cold Meds From Shelves After Report Deems Them to Be Useless

FRIDAY, Oct. 20, 2023 (HealthDay News) -- CVS Health plans to pull cold medications that contain phenylephrine from its store shelves after federal regulators determined recently that the decongestant does not work.
Oral phenylephrine is an active ingredient in such well-known products as Sudafed and Dayquil. A U.S. Food and Drug Administration advisory committee ruled last month that the ingredient was useless in easing congestion.
"We are removing certain oral cough and cold products that contain phenylephrine as the only active ingredient from CVS Pharmacy stores," the company told CBS MoneyWatch. "Other oral cough and cold products will continue to be offered to meet consumer needs."
Another drugstore chain, Walgreens, said it "follows FDA regulations," but did not say if it would stop selling the medications.
"We are closely monitoring the situation and actively partnering with the Walgreens Office of Clinical Integrity and suppliers on appropriate next steps," a spokesperson told CBS MoneyWatch.
Medications that contain phenylephrine account for $1.8 billion in annual sales, according to FDA data.
Related Posts
La ómicron asola a los hospitales de EE. UU., que ya están desbordados
MIÉRCOLES, 26 de enero de 2022 (HealthDay News) -- Los hospitales de EE. UU....
Pregnant American Women Are Facing Higher Exposures to Chemicals
TUESDAY, May 10, 2022 (HealthDay News) -- Exposure to potentially harmful...
Continuation of Anti-TNF for IBD After 24 Weeks of Pregnancy Beneficial
MONDAY, Sept. 26, 2022 (HealthDay News) -- For women with inflammatory bowel...
Too Few People Treated for Opioid Use Get Anti-Overdose Med
FRIDAY, May 13, 2022 (HealthDay News) -- A potentially lifesaving drug that...
